What is ALUR's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.00B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ALUR?

P/E (TTM) is n/a and 52-week range is $0.02 to $31.50 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ALUR figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ALUR?

The company profile lists revenue (TTM) near $14M, net income (TTM) near -$3.75B, EPS (TTM) near -$39.87 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Allurion Technologies Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Natick, Massachusetts, US, 1M shares outstanding, ISIN US02008G2012 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Allurion Technologies Inc

$ALUR

Consumer Discretionary · Diversified Consumer Services

Run Scenarios

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Allurion Technologies, Inc. develops treatments for obesity. The company is headquartered in Natick, Massachusetts and currently employs 38 full-time employees. The company went IPO on 2021-03-29. The firm offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.

Employees

Website

www.allurion.com/en

IPO

2021-03-29

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NEW YORK STOCK EXCHANGE, INC.

ISIN

US02008G2012

Headquarters

Natick, Massachusetts, US

Shares outstanding

NAICS sector

Information

Institutional ownership

7.90%

Browse other companiesFree AI scores and summaries for more stocks

Allurion Technologies Inc (ALUR) Stock Analysis & Quote